526853 Stock Overview
Provides pharmaceutical packaging research solutions in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Bilcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹54.63 |
| 52 Week High | ₹95.40 |
| 52 Week Low | ₹51.00 |
| Beta | 1.11 |
| 11 Month Change | -7.91% |
| 3 Month Change | -13.71% |
| 1 Year Change | -23.96% |
| 33 Year Change | -31.93% |
| 5 Year Change | 161.39% |
| Change since IPO | -51.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 526853 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -1.2% | 1.2% | 0.3% |
| 1Y | -24.0% | 48.2% | 27.3% |
Return vs Industry: 526853 underperformed the Indian Life Sciences industry which returned 47.9% over the past year.
Return vs Market: 526853 underperformed the Indian Market which returned 27.2% over the past year.
Price Volatility
| 526853 volatility | |
|---|---|
| 526853 Average Weekly Movement | 6.3% |
| Life Sciences Industry Average Movement | 6.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 526853 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 526853's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 73 | n/a | www.bilcare.com |
Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for packaging of solid dosage pharmaceutical products. It also offers CR, blister, and lidding foils; blister films and laminates.
Bilcare Limited Fundamentals Summary
| 526853 fundamental statistics | |
|---|---|
| Market cap | ₹1.29b |
| Earnings (TTM) | -₹401.71m |
| Revenue (TTM) | ₹7.65b |
0.2x
P/S Ratio-3.2x
P/E RatioIs 526853 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 526853 income statement (TTM) | |
|---|---|
| Revenue | ₹7.65b |
| Cost of Revenue | ₹5.27b |
| Gross Profit | ₹2.38b |
| Other Expenses | ₹2.78b |
| Earnings | -₹401.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | -17.06 |
| Gross Margin | 31.10% |
| Net Profit Margin | -5.25% |
| Debt/Equity Ratio | 120.5% |
How did 526853 perform over the long term?
See historical performance and comparison